arrow_back Back Filing freshness 10-K Q4 FY2026 SEC EDGAR

InnovAge Holding Corp.

INNV
$9.01 ▼ -1.65 (-15.49%) at close
Healthcare ·Services-Health Services ·USServices-Health Services
28 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
35
Health
Weak
Bearish
auto_awesome

Analytical Summary

InnovAge Holding Corp. faces fundamental challenges with weakness in Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap
Dividend Yield
Revenue Growth 18.3%
Op. Margin 3.9%
ROIC 2.8%
FCF / Share None
Trailing P/E 150.2x
Price / Book 5.2x
FCF Yield
Debt / Equity 0.21
info Valuation on last close. End-of-day price, Sep 23, 2026.

28-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$261.95M
↑ +18.3%
Net Income Profit after all expenses
$8.29M
↑ +128.1%
Operating Margin Operating profit as % of sales
3.9%
↑ +133.6% 25th
FCF / Share Free cash flow per share
$0.11
↓ -23.5%
Long-Term Debt Long-term obligations
$48.81M
↓ -11.9%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile

Health Breakdown

Profitability
30
Returns
37
Financial Health
58
Cash Quality
1

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 8 years · 28 quarters